All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by AbbVie, BeOne Medicines, Johnson & Johnson, Roche and sobi, and supported through educational grants from Bristol Myers Squibb, Incyte and Lilly. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lymphoma & CLL content recommended for you
Lymphoma Hub Satellite Symposium—Summary and roundtable discussion
Kieron Dunleavy
Gilles Salles
Marie José Kersten
Francesc Bosch
Astrid PavlovskyAt this year’s European School of Haematology (ESH) ‘2nd How to Diagnose and Treat: Lymphoma’ conference, the Lymphoma Hub hosted a virtual Satellite Symposium on the management and treatment of patients with relapsed/refractory (R/R) lymphoma.
The symposium brought together a panel of international experts, who gave their opinion on two distinct patient cases, presented in Figure 1. Click to see the presentations by Kieron Dunleavy, Marie José Kersten, Astrid Pavlovsky and Francesc Bosch.
Figure 1. A R/R DLBCL patient case and B R/R CLL patient case
Following a diverse selection of presentations by the four panelists, there was an exciting roundtable discussion answering any questions submitted by the audience; watch it below.
Satellite Symposium | Roundtable discussion
In the lead up to the virtual symposium, the Lymphoma Hub conducted a series of Twitter polls to gain insight into the audience’s understanding of, and interests within, the field of R/R lymphoma (Figure 2). Take a look at the Lymphoma Hub symposium content in our Twitter moment.
Figure 2. Results of the Lymphoma Hub Satellite Symposium Twitter polls
Below, Lymphoma Hub Chair Gilles Salles shares the highlights from the symposium.
Highlights of the Lymphoma Hub Satellite Symposium
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
Your opinion matters
In your experience, when do most CRS/ICANS events occur after lisocabtagene maraleucel infusion?